AGN (72.61,+5.5%) made an all-time high today on the migraine news. It now has a market cap of about $23B (!), which is not bad for a “specialty” drug company.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”